The prognostic role of variations in tumour markers (CEA, CA15.3) in patients with metastatic breast cancer treated with CDK4/6 inhibitors

The prognostic role of variations in tumour markers (CEA, CA15.3) in patients with metastatic breast cancer treated with CDK4/6 inhibitors

Tumour markers have no established role in the monitoring of the course of metastatic breast cancer during antineoplastic therapy, yet cancer antigen 15.3 (CA15.3) and carcinoembryonic antigen (CEA) are commonly used in clinical practice to aid in the early detection of progression of disease (PD)....

Full description

Saved in:
Bibliographic Details
Main Authors: Federico Sottotetti (Author), Elisa Ferraris (Author), Barbara Tagliaferri (Author), Raffaella Palumbo (Author), Erica Quaquarini (Author), Cristina Teragni (Author), Emanuela Balletti (Author), Claudia Leli (Author), Andrea Premoli (Author), Ludovica Mollica (Author), Silvia Puglisi (Author), Silvia Sardi (Author), Alberto Malovini (Author), Paolo Pedrazzoli (Author), Antonio Bernardo (Author)
Format: Book
Published: BioExcel Publishing Ltd, 2022-09-01T00:00:00Z.
Subjects:
article
Online Access:Connect to this object online.
Tags: Add Tag
No Tags, Be the first to tag this record!

Internet

Connect to this object online.

3rd Floor Main Library

Holdings details from 3rd Floor Main Library
Call Number: A1234.567
Copy 1 Available

Similar Items